Home › NDC Lookup › RxCUI directory › RxCUI 805855

Candesartan cilexetil 32 MG / hydrochlorothiazide 25 MG Oral Tablet [Atacand HCT] — RxCUI 805855

RxNorm drug concept · Semantic branded drug
RxCUI 805855 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI805855
Official nameCandesartan cilexetil 32 MG / hydrochlorothiazide 25 MG Oral Tablet [Atacand HCT]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAtacand HCT 32/25 Oral Tablet; Atacand HCT 32 MG / 25 MG Oral Tablet; candesartan cilexetil 32 MG / HCTZ 25 MG Oral Tablet [Atacand HCT]
FDA products mapped3
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Candesartan: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats high blood pressure in adults and in children 1 to under 17 years. It also treats heart failure in adults, where it helps reduce hospital stays and cardiovascular death....
  • Take it by mouth, usually once a day, with or without food. Your prescriber may split the daily amount into two doses. For heart failure, the dose is often raised gradually, so fol...
  • The most common ones are dizziness, headache, back pain, and cold-like symptoms such as a sore throat or runny nose. Call your doctor if you feel faint, notice swelling of the face...
  • Check with me first. NSAIDs like ibuprofen can weaken candesartan's effect and strain the kidneys. Potassium-based salt substitutes and potassium supplements can push your potassiu...
📖 Read our full Candesartan guide →

🕸️ Concept Web — How Candesartan cilexetil 32 MG / hydrochlorothiazid... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Candesartan cilexetil 32 MG / hydrochlorothiazide 25 MG Oral Tablet [Atacand HCT] RxCUI 805855

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Candesartan 214354
    • Hydrochlorothiazide 5487
    • Candesartan / hydrochlorothiazide 284628
    • Candesartan cilexetil 135481
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Atacand HCT 284662
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Candesartan / hydrochlorothiazide Oral Tablet 374934
    • Candesartan cilexetil / hydrochlorothiazide Oral Tablet 2645863
    • Candesartan / hydrochlorothiazide Oral Product 1156609
    • Candesartan / hydrochlorothiazide Pill 1156610
    • Candesartan cilexetil / hydrochlorothiazide Oral Product 2659327
    • Candesartan cilexetil / hydrochlorothiazide Pill 2663669
    • Candesartan / hydrochlorothiazide Oral Tablet [Atacand HCT] 805854
    • Candesartan cilexetil / hydrochlorothiazide Oral Tablet [Atacand HCT] 2658646
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 17 of 22 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Candesartan cilexetil 32 MG / hydrochlorothiazide 25 MG Oral Tablet SCD · 802749
  • Candesartan cilexetil 32 MG SCDC · 577780
  • Hydrochlorothiazide 25 MG SCDC · 316049
  • Candesartan / hydrochlorothiazide Oral Tablet SCDF · 374934
  • Candesartan cilexetil / hydrochlorothiazide Oral Tablet SCDFP · 2645863
  • Candesartan / hydrochlorothiazide Oral Product SCDG · 1156609
  • Candesartan / hydrochlorothiazide Pill SCDG · 1156610
  • Candesartan cilexetil / hydrochlorothiazide Oral Product SCDGP · 2659327
  • Candesartan cilexetil / hydrochlorothiazide Pill SCDGP · 2663669

Brand-Name Concepts

  • Candesartan cilexetil 32 MG / hydrochlorothiazide 25 MG [Atacand HCT] SBDC · 805853
  • Candesartan / hydrochlorothiazide Oral Tablet [Atacand HCT] SBDF · 805854
  • Candesartan cilexetil / hydrochlorothiazide Oral Tablet [Atacand HCT] SBDFP · 2658646
  • Atacand HCT Oral Product SBDG · 1172183
  • Atacand HCT Pill SBDG · 1172182
  • Atacand HCT BN · 284662

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 805855 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
62559-0650-90 90 TABLET in 1 BOTTLE (62559-650-90) ATACAND HCT ANI Pharmaceuticals, Inc. 2018-10-01
62559-0651-90 90 TABLET in 1 BOTTLE (62559-651-90) ATACAND HCT ANI Pharmaceuticals, Inc. 2018-10-01
62559-0652-90 90 TABLET in 1 BOTTLE (62559-652-90) ATACAND HCT ANI Pharmaceuticals, Inc. 2018-10-01
Observed labelers: ANI Pharmaceuticals, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.